JW Holdings exports antibiotics to Luxembourg for COVID-19 treatment purposes
[Asia Economy Reporter Dongwoo Lee] JW Holdings announced on the 14th that it will urgently export antibiotics used for the treatment of COVID-19 patients to Luxembourg and the Republic of South Africa.
The product exported to Luxembourg is JW Levofloxacin Injection. It is a quinolone antibiotic that has the effect of alleviating respiratory inflammation. It was supplied at the request of the Luxembourg delegation in Korea. It will be shipped on the 19th.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump Puts Iran Strike on Hold One Day Before Attack... "Full-Scale Offensive If Talks Fail"
- [New York Stock Market] Mixed Close Amid Tech Stock Declines and Stalled Ceasefire Talks
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Pripenem Injection is known to be used for the treatment of severe infectious diseases such as pneumonia.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
